Dgchem Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
- Revenue Growth 62.30%
- Profit Growth 16.53%
- Ebitda 30.59%
- Net Worth 102.24%
- Total Assets 82.53%
About Dgchem Labs
Dgchem Labs Private Limited (DLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 September 2018 (Six years and four months 16 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999DL2018PTC338937
-
Company No.
338937
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Sep 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dgchem Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharni Kant
|
Director | 19-Sep-2018 | Current |
|
Gavita Jha
|
Director | 19-Sep-2018 | Current |
Financial Performance of Dgchem Labs.
Dgchem Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 62.3% increase. The company also saw a substantial improvement in profitability, with a 16.53% increase in profit. The company's net worth Soared by an impressive increase of 102.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dgchem Labs?
In 2021, Dgchem Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Diagomet Laboratories Private LimitedDharni Kant and Gavita Jha are mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2023 | Axis Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Dgchem Labs?
Dgchem Labs has a workforce of 9 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dgchem Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dgchem Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.